Get startedLog in
    Picture of Kdventures AB logo

    KDV B — Kdventures AB News Story

    0.000.00%
    se flag iconLast trade - 00:00
    FinancialsSpeculativeMicro CapSucker Stock
    All News

    Brief: Pharmnovo Receives Positive FDA Feedback On Drug Candidate PN6047

    Picture of Kdventures AB logoKdventures AB
    12/03/2025 14:40
    March 12 (Reuters) - Karolinska Development AB KDEV.ST:

PHARMNOVO RECEIVES POSITIVE FDA FEEDBACK ON DRUG CANDIDATE PN6047

PHARMNOVO TO APPLY FOR IND APPROVAL FROM FDA BY END OF 2025

Source text: ID:nGNE99R24d

Further company coverage: KDEV.ST

 (Gdansk Newsroom)

 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

    Recent news on Kdventures AB

    See all news